Home
Archives
Contact
About
Biotechnology Books
Publishing Opportunities
Pharma Industry Reports
The business of biotechnology
Twitter
Linkedin
Rss
Blog - Latest News
You are here:
Home
»
General Biotechnology
»
Financial Snapshot For March 2004
April 15, 2004
15
Apr
2004
Financial Snapshot For March 2004
Financial Snapshot For March 2004: Looking Good 04/14/2004
Share this:
Email
Facebook
LinkedIn
Twitter
Google +1
0 Comments
/
0
Likes
/
0
Tweets
/
in
General Biotechnology
0
replies
Leave a Reply
Want to join the discussion?
Feel free to contribute!
Leave a Reply
Cancel reply
Get updates by email
Your email:
BiotechBlog’s
Editor
Yali Friedman lives in Washington, DC and is author of
Building Biotechnology
and
other books
; founder of
DrugPatentWatch
; and chief editor of the
Journal of Commercial Biotechnology
.
Read More...
Network
and Share
Categories
Select Category
Biotechnology Book Reviews
Biotechnology Industry News
Biotechnology Videos
Featured
General Biotechnology
Guest content
Talks and Publications
Uncategorized
Featured Content
Introducing BiologicPatentWatch: Biotechnology Industry Competitive Intelligence
Biotechnology and Pharmaceutical Industry Infographics
DNA-o-gram generator — Send a message in the language of life
Popular Posts
Supreme Court Both Invalidates & Upholds Myriad Patents
About
The Developing World’s Agricultural Biotech Potential: An Asian-African Snapshot
Association for Molecular Pathology v Myriad: Attorneys React
Recommended
Reading
Recent
Comments
Making sense of the confusing Supreme Court DNA patent ruling | diveintotech
on
Supreme Court Both Invalidates & Upholds Myriad Patents
Anonymous on
Supreme Court Both Invalidates & Upholds Myriad Patents
BiotechBlog | Introducing DrugChatter -- Analyzing public opinion on popular drugs - BiotechBlog
on
Contact
BiotechBlog | Association for Molecular Pathology v Myriad: Attorneys React - BiotechBlog
on
After Myriad Oral Argument, Supreme Court Set to Decide Patentability of Isolated Human DNA Molecules
Susan K Finston
on
The Answers are in the Crowd? (Part 2) [live from #bio2013]
Translator
←
Drug Company Accused of Bribing Doctors
(previous entry)
(next entry)
Are biotech jobs next to go?
→
© Copyright -
BiotechBlog
— A
thinkBiotech
product
Send to Email Address
Your Name
Your Email Address
Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Leave a Reply
Want to join the discussion?Feel free to contribute!